ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      18,927.60
      -0.06%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      72.975
      0.82%
      Bitcoin
      62,077.74
      0.66%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Moleculin Biotech Inc (MBRX)

      7. Moleculin Biotech Inc (MBRX) Financials

      Moleculin Biotech Inc

      Moleculin Biotech Inc (MBRX)

      NASDAQ
      2.47
      0.13
      (5.56%)
      Closed September 18 4:00PM
      Delayed by 15 minutes
      2.42
      -0.05
      (-2.02%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Moleculin Biotech Inc Financial Summary

      The current MBRX market cap is 7.01M. The company's latest EPS is USD -10.4820 and P/E is -0.23.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -6.41M-5.95M-8.92M-6.68M-6.19M
      Net Income -5.98M-5.61M-10.27M-4.97M-4.32M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -17.52M-19.74M-22.97M-30.64M-29.63M
      Net Income -13.21M-17.36M-15.89M-29.03M-29.77M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 47.12M39.52M38.22M30.85M25.58M
      Total Liabilities 6.85M4.39M12.14M9.26M7.87M
      Total Equity 40.27M35.14M26.07M21.59M17.71M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 25.24M29.03M84.09M57.42M38.22M
      Total Liabilities 9.66M11.27M5.1M5.23M12.14M
      Total Equity 15.57M17.76M78.99M52.19M26.07M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -11.14M-18.69M-24.1M-6.72M-12.67M
      Investing -15k-43k-124k N/A -13k
      Financing 190k186k4.65M N/A -25k
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -17.2M-17.77M-18.95M-27.64M-24.1M
      Investing -51k-374k-19k-67k-124k
      Financing 20.85M22.55M74.72M-23k4.65M

      Stats and Ratios

      Market Cap 7.01M
      Price to Earnings Ratio -0.23
      Price to Sales Ratio 0
      Price to Cash Ratio 0.29
      Price to Book Ratio 0.26
      Dividend Yield -

      Share Statistics

      Shares Outstanding 2.84M
      Average Volume (1 week) 14.02k
      Average Volume (1 Month) 20.1k
      52 Week Change -58.83%
      52 Week High 15.75
      52 Week Low 2.115
      Spread (Intraday) 0.16 (6.45%)

      Company Info

      Company Name Moleculin Biotech Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.moleculin.com
      Industry pharmaceutical preparations (2834)